Cite
Fiandaca MS, Zhong X, Cheema AK, et al. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Front Neurol. 2015;6:237doi: 10.3389/fneur.2015.00237.
Fiandaca, M. S., Zhong, X., Cheema, A. K., Orquiza, M. H., Chidambaram, S., Tan, M. T., Gresenz, C. R., FitzGerald, K. T., Nalls, M. A., Singleton, A. B., Mapstone, M., & Federoff, H. J. (2015). Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Frontiers in neurology, 6237. https://doi.org/10.3389/fneur.2015.00237
Fiandaca, Massimo S, et al. "Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease." Frontiers in neurology vol. 6 (2015): 237. doi: https://doi.org/10.3389/fneur.2015.00237
Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Front Neurol. 2015 Nov 12;6:237. doi: 10.3389/fneur.2015.00237. eCollection 2015. PMID: 26617567; PMCID: PMC4642213.
Copy
Download .nbib